MIRA Pharmaceuticals, Inc. /
SKNY Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. adds SKNY Pharmaceuticals, Inc.




Source for the buyer and target: MIRA Pharmaceuticals, Inc.
For the buyer and target.
“On September 29, 2025, MIRA Pharmaceuticals, Inc. (the “Company”) completed its acquisition of SKNY Pharmaceuticals, Inc. (“SKNY”) pursuant to the previously announced merger agreement (the “Merger Agreement”).”
Published 30 Sep 2025
Open the sourceWhat happened
MIRA Pharmaceuticals, Inc. completed its acquisition of SKNY Pharmaceuticals, Inc. on Sept. 29, 2025. The transaction exchanged restricted shares of MIRA Pharmaceuticals, Inc. common stock for SKNY Pharmaceuticals, Inc. shares. [01]
SKNY Pharmaceuticals, Inc. contributed $5 million in marketable securities to MIRA Pharmaceuticals, Inc. at closing. [01]
The source
Everything on this page comes from the source below, quoted word for word.
MIRA Pharmaceuticals, Inc. adds SKNY Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“MIRA Pharmaceuticals, Inc. adds SKNY Pharmaceuticals, Inc. MIRA Pharmaceuticals, Inc. completed its acquisition of SKNY Pharmaceuticals, Inc. on Sept. 29, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly